{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:50:50Z","timestamp":1773294650176,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> To assess the effectiveness and tolerability of ziprasidone for treating pediatric mania.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> This was an eight\u2010week, open\u2010label, prospective study of ziprasidone monotherapy (57.3\u2003\u00b1\u200333.9\u2003mg\/day) in 21 bipolar youth [manic, mixed, or bipolar not otherwise specified (NOS); 6\u201317\u2003years old]. Assessments included the Young Mania Rating Scale (YMRS), Clinical Global Impressions\u2010Improvement scale (CGI\u2010I), and Brief Psychiatric Rating Scale (BPRS). Adverse events were assessed through spontaneous self\u2010reports, vital signs, weight monitoring, and laboratory analysis.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Fourteen of the 21 youth (67%) completed the study. Ziprasidone treatment was associated with clinically and statistically significant improvement in mean YMRS scores (\u221210.8\u2003\u00b1\u20038.4, p\u2003&lt;\u20030.0001) and 57% had a CGI\u2010I \u22642 at endpoint. Ziprasidone was well tolerated with no statistically significant increase in body weight (0.6\u2003\u00b1\u20030.4\u2003kg, p\u2003=\u20030.2) or QTc interval (\u22123.7\u2003\u00b1\u20034.7, p\u2003=\u20030.5).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Open\u2010label ziprasidone treatment was associated with a significant short\u2010term improvement of symptoms of pediatric bipolar disorder. Future placebo\u2010controlled, double\u2010blind studies are warranted.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2007.00450.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T14:30:20Z","timestamp":1284388220000},"page":"888-894","source":"Crossref","is-referenced-by-count":41,"title":["A prospective open\u2010label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder"],"prefix":"10.1111","volume":"9","author":[{"given":"Joseph","family":"Biederman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Mick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Aleardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_6_4_2","first-page":"251","article-title":"Tardive and withdrawal dyskinesia in autistic children: a prospective study","volume":"24","author":"Campbell M","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"e_1_2_6_7_2","first-page":"57","volume-title":"Bipolar Disord","author":"Jones M","year":"2003"},{"key":"e_1_2_6_8_2","first-page":"70","volume-title":"Bipolar Disord","author":"Mullen JA","year":"2003"},{"key":"e_1_2_6_9_2","first-page":"74","volume-title":"Bipolar Disord","author":"Paulsson B","year":"2003"},{"key":"e_1_2_6_10_2","first-page":"35","volume-title":"Bipolar Disord","author":"Brecher M","year":"2003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/10445460152595568"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.03.019"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.311"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000194567.63289.97"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1207\/S15374424JCCP3104_15"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830230069010"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.13.3.384"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0148-9062(75)90418-0"},{"key":"e_1_2_6_22_2","first-page":"839","article-title":"CGI (Clinical Global Impression) Scale \u2013 NIMH","volume":"21","author":"National Institute of Mental Health","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200006000-00009"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00012"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.58"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0401"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199507000-00010"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1999.9.247"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/10445460050167296"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454603322163871"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000138228.59938.c3"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2007.00450.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2007.00450.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:58:25Z","timestamp":1696939105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2007.00450.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1399-5618.2007.00450.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00450.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}